TABLE 2 Clinicopathological Parameters of the Four Patients with Post-Transplantation Lymphoproliferative Disorders
Gender/Age | Allograft | Time After Transplantation | Location | Lineage | Type | Origin | EBV | Cause of Death | Survival After Diagnosis of PTLD |
|---|---|---|---|---|---|---|---|---|---|
M/37 | Liver | 8 mo | Liver | B | DLCL | Donor | Positive | Allograft rejection | 11 mo |
F/29 | Kidney | 5 mo | Kidney | B | DLCL | Donor | Positive | Chronic renal failure | 50 mo |
F/52 | Liver | 9 mo | Liver | B | DLCL | Donor | ND | Pneumonia | 18 mo |
F/67 | Liver | 11 mo | Liver & lung | B | DLCL | Recipient | ND | PTLD | 12 mo |
